Related Experiment Video
Updated: May 8, 2026
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Inflammatory Prognostic Index May Predict the Development of Contrast-Induced Nephropathy in Patients with ST-Segment
Yusuf Can1, Emre Eynel2, Şevval Özdemir2
1Department of Cardiology, Sakarya University School of Medicine, Turkey.
Angiology
|May 7, 2026
Summary
The inflammatory prognostic index (IPI) effectively predicts contrast-induced nephropathy (CIN) in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI). IPI shows superior performance over other inflammation markers for CIN risk assessment.
Area of Science:
- Cardiology
- Nephrology
- Inflammation markers
Background:
- Contrast-induced nephropathy (CIN) is a significant complication in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI).
- Predictive models for CIN are crucial for timely intervention and improved patient outcomes.
- Inflammation-based indices are increasingly recognized for their prognostic value in cardiovascular diseases.
Purpose of the Study:
- To evaluate the predictive performance of inflammation-based indices for CIN development in STEMI patients undergoing pPCI.
- To specifically assess the utility of the inflammatory prognostic index (IPI) in predicting CIN.
- To compare the discriminative performance of IPI against other established inflammation markers.
Main Methods:
- Retrospective analysis of 563 STEMI patients undergoing pPCI.
- Calculation and comparison of admission inflammation-based indices: IPI, neutrophil-to-lymphocyte ratio (NLR), C-reactive protein-to-albumin ratio (CAR), and systemic immune inflammation index (SII).
- Multivariate logistic regression and receiver operating characteristic (ROC) curve analysis to determine independent predictors and discriminative performance.
Main Results:
- CIN developed in 15.1% of patients.
- Admission IPI was significantly higher in patients who developed CIN (10.9 vs 4.8, P < .001).
- IPI independently predicted CIN (OR 1.31, P = .013) and demonstrated superior discriminative performance (AUC 0.826) compared to NLR (AUC 0.691), CAR (AUC 0.712), and SII (AUC 0.704).
- An IPI cutoff of 8.35 predicted CIN with 82.4% sensitivity and 65.9% specificity.
Conclusions:
- The inflammatory prognostic index (IPI) is a superior predictor of contrast-induced nephropathy (CIN) in STEMI patients undergoing pPCI.
- IPI offers better discriminative ability for CIN risk compared to NLR, CAR, and SII.
- Utilizing IPI may aid in identifying high-risk patients for CIN and guiding preventative strategies.
Related Concept Videos
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...